Get the Stockscreener App
122.07
1.59%
1.92
State Street Spdr S P Biotech Etf stock is traded at $122.07, with a volume of 7.11M.
It is up +1.59% in the last 24 hours and down -1.09% over the past month.
See More
Previous Close:
$120.15
Open:
$119.99
24h Volume:
7.11M
Relative Volume:
0.70
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.32%
1M Performance:
-1.09%
6M Performance:
+43.20%
1Y Performance:
+32.37%
1-Day Range:
$119.76
$122.19
1-Week Range:
$118.28
$122.80
52-Week Range:
$66.66
$126.50
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Name
State Street Spdr S P Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare XBI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
122.02 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
341.25 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
692.01 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
695.08 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
269.31 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
623.72 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Stock (XBI) Latest News
As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight - Benzinga
As Artificial Intelligence Stocks Surge in Value, Health Care ETFs Take Center Stage for Growth - Bitget
Biotech and Pharma Stocks Tumble as Investors Race into Energy - Barron's
Biotech: Time For A Pause To Start 2026 - Seeking Alpha
The Year-End 2025 Biotech Rally And What It Means For 2026 - Benzinga
Chart of the Week: Moderna Stock May Be Finding a Bottom - Barron's
Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock - MSN
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - sharewise.com
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - sharewise.com
Look What I Found While Bargain Hunting in the Biotech Sector - TheStreet Pro
Beyond S&P 500: KKR Flags Asia, Biotech, Infrastructure As Next 'High-Grade' Trades For 2026 - Benzinga
If You Invested $100 In State Street SPDR S&P Biotech ETF Stock 20 Years Ago, You Would Have This Much Today - Benzinga
Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus - Sahm
Why Is Trinity Biotech Stock Soaring Tuesday? - Benzinga
Toast, Uber And More On CNBC's 'Final Trades'Baidu (NASDAQ:BIDU), Lyft (NASDAQ:LYFT) - Benzinga
If These Biotech Stocks Pull Back, I'll Be Ready to Pull the Trigger - TheStreet Pro
Biotech Was ‘En Fuego’ — Now I've Got My Eyes on Another Market Laggard - TheStreet Pro
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? - MSN
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
I'm Eyeing One Big, One Little Biotech for a Repeat Trade - TheStreet Pro
Should You Invest in the iShares Biotechnology ETF (IBB)? - sharewise.com
Should State Street SPDR MSCI USA StrategicFactors ETF (QUS) be on your investing radar? - MSN
2 Brilliant Biotech ETFs to Watch in 2026 - AOL.com
Biotech ETFs Gain Momentum with Promising Gains and Risks - cointurk finance
Should you invest in the State Street SPDR S&P Regional Banking ETF (KRE)? - MSN
Should State Street SPDR S&P Dividend ETF (SDY) be on your investing radar? - MSN
Should You Invest in the SPDR S&P Homebuilders ETF (XHB)? - MSN
Eight stock picks to play one of the healthiest corners of the market - MarketWatch
Opinion: The Fed cut rates. Biotech didn’t notice. - MarketWatch
3 Undervalued ETFs to Buy Before 2026 - Yahoo Finance
Should you invest in the State Street SPDR S&P Software & Services ETF (XSW)? - MSN
Biotech ETF (XBI) hits new 52-week high - MSN
Biotech ETF (XBI) Hits New 52-Week High - TradingView — Track All Markets
The Biotech Industry Is Healthier Than Investors Think. The Stocks to Watch. - Barron's
The Biotech Industry Is Healthier Than Investors Think. These Are the Stocks to Watch. - Barron's
Should State Street SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar? - MSN
Meet the New AI Winners: Alphabet, Tesla and Even Big Pharma and Biotech - Barron's
1 Sector ETF to Avoid Like the Plague in November - AOL.com
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - sharewise.com
ETFs Investing in ArriVent BioPharma, Inc. Stocks - TradingView
Should State Street SPDR S&P 400 Mid Cap Growth ETF (MDYG) Be on Your Investing Radar? - MSN
Gold Miners Are Crushing Gold: UBS Says Grab These 5 Cheap Picks - AOL.com
IYK vs. XLP: Top Holdings Could Make the Difference - AOL.com
State Street SPDR and iShares ETFs Deliver Strong Growth Without AI Stocks - cointurk finance
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - sharewise.com
This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys - AOL.com
Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year - AOL.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Apple, Taiwan Semiconductor Manufacturing And More On CNBC's 'Final Trades' - Benzinga
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - sharewise.com
Best-Performing ETFs of Last Week: Healthcare Rules - sharewise.com
State Street Spdr S P Biotech Etf Stock (XBI) Financials Data
There is no financial data for State Street Spdr S P Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):